XML 98 R70.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Collaborations - Bayer HealthCare Pharmaceuticals Inc. (Details)
$ in Millions
12 Months Ended
Dec. 31, 2019
USD ($)
country
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 23,362 $ 23,747 $ 22,849
Collaborative Arrangement with Bayer [Member] | Nexavar [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Number of countries product is marketed and sold | country 100    
Collaboration, royalty percentage in the high 30s 30.00%    
Percentage of net profits after deducting certain partner related costs 50.00%    
Collaborative Arrangement with Bayer [Member] | Nexavar [Member] | Other revenues [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration profit $ 210 164 161
Collaborative Arrangement with Bayer [Member] | Royalty [Member] | Other revenues [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 79 $ 91 $ 133